ZIM results on a going concern basis

Bob,

Redeye is an innovative drip type system that bridges the gap between the old bog standard gravity based drip, used for things like saline and plasma, and the pump system. Pump based drip systems are very expensive, $2000+, but are neccessary in order to ensure very accurate dosages of drugs are delivered into the body. Too much or too little of the drug can cause severe discomfort for the patient and in some cases death. Redeye can do most if not all that the pump does, but is much cheaper, £500 or so. The product has had exhaustive testing and has wowed all those involved in the trials, and goes on sale Jan 04.
It goes without saying that hospitals will often have a dozen or more pumps, for use in intensive care, pre natal departments etc.

As to share price target...Bob, you're the uncle! If the syringe drivers take off, then £1 within 18 months is not unreasonable.